نتایج جستجو برای: hematopoietic stem cell transplantation

تعداد نتایج: 1898560  

Amir Ali Hamidieh

The introduction and evolution of hematopoietic stem cell transplantation (HSCT) could be traced back to 1950s, to the studies on interactions among irradiation, covering spleen and bone marrow from it and injection of bone marrow cells. Today, HSCT is considered a well-established, effective and promising means of therapy for various malignant and non-malignant medical conditions, both in chil...

Journal: :iranian journal of pharmaceutical research 0
maria tavakoli affiliation mahdi tabarraee hematology and oncology center, taleghani hospital, shahid beheshti university of medical sciences, tehran, iran mahshid mehdizadeh taleghani bone marrow transplantation center, taleghani hospital, shahid beheshti university of medical sciences, evin, tehran, iran. abbas hajifathali taleghani bone marrow transplantation center, taleghani hospital, shahid beheshti university of medical sciences, evin, tehran, iran. mojtaba ghadiany hematology and oncology center, taleghani hospital, shahid beheshti university of medical sciences, tehran, iran hmid rezvani hematology and oncology center, taleghani hospital, shahid beheshti university of medical sciences, tehran, iran

background: antibiotic prophylaxis is usually used in allogenic stem cell transplantation, but its use in autologous stem cell transplantation (asct) is controversial. we evaluated the efficacy of ciprofloxacin prophylaxis in asct. materials and methods: to identify the efficacy of ciprofloxacin on the incidence of neutropenic fever and its complications, 72 patients had been admitted to talegh...

Journal: :international journal of hematology-oncology and stem cell research 0
mohammad vaezi hematologist- oncologist, hematology- oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran cyrous gharib hematologist- oncologist, gilan university of medical sciences, gilan, iran maryam souri 3hematology- oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran ardeshir ghavamzadeh professor of medicine, hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran

background: hematopoietic stem cell transplantation (hsct) is currently the only curative treatment for acute leukemia. as hsct improves the long-term survival, it is necessary to assess the late-onset complications affecting the quality of life following hsct. subjects and methods: the study included 122 patients (65 male, 57 female) with leukemia (72 aml and 50 all) who received transplants f...

Journal: :international journal of hematology-oncology and stem cell research 0
mahdi jalili hematology, oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran kamran alimoghaddam hematology, oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran amir ali hamidieh hematology, oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran amir hamdi hematology, oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran mohammad jahani hematology, oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran babak bahar hematology, oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran

introduction: severe acquired aplastic anemia (saa) is a rare disease and matched related hematopoietic stem cell transplantation (hsct) is the treatment of choice especially in pediatric patients. immunosuppressive therapy is the alternative treatment in patients who do not have a donor. we retrospectively analyzed patients who received allogeneic hsct at our institution. methods: between 1991...

Journal: :international journal of hematology-oncology and stem cell research 0
ardeshir ghavamzadeh hematology- oncology and stem cell transplantation, shariati hospital, tehran university of medical sciences, tehran, iran atefeh masnavi hematology- oncology and stem cell transplantation, shariati hospital, tehran university of medical sciences, tehran, iran farnaz khatami hematology- oncology and stem cell transplantation, shariati hospital, tehran university of medical sciences, tehran, iran arash jalali hematology- oncology and stem cell transplantation, shariati hospital, tehran university of medical sciences, tehran, iran

introduction: acute myelogenous leukemia (aml) is a clonal  malignant disease of hematopoietic tissue. the early use of  hematopoietic stem cell transplantation (hsct) for aml was for patients with advanced stages of disease, usually while in relapse, in second or subsequent remission, or with resistant disease. patients and methods: from march 1991 until february 2008, 356(65%) registered allo...

Journal: :iranian journal of blood and cancer 0
soheila zareifar associate professor of pediatric hematology-oncology, department of pediatrics, shiraz university of medical sciences, shiraz, iranسازمان اصلی تایید شده: دانشگاه علوم پزشکی شیراز (shiraz university of medical sciences) babak abdolkarimi assistant professor of pediatric hematology-oncology, lorestan university of medical sciences, khoramabad, iranسازمان اصلی تایید شده: دانشگاه علوم پزشکی لرستان (lorestan university of medical sciences) mohamadreza bordbar associate professor of pediatric hematology-oncology, department of pediatrics, shiraz university of medical sciences, shiraz, iranسازمان اصلی تایید شده: دانشگاه علوم پزشکی شیراز (shiraz university of medical sciences) mehran karimi professor of pediatric hematology-oncology, department of pediatrics, shiraz university of medical sciences, shiraz, iranسازمان اصلی تایید شده: دانشگاه علوم پزشکی شیراز (shiraz university of medical sciences) fazl saleh fellowship of pediatric hematology-oncology, department of pediatrics, shiraz university of medical sciences, shiraz, iranسازمان اصلی تایید شده: دانشگاه علوم پزشکی شیراز (shiraz university of medical sciences) omidreza zekavat associate professor of pediatric hematology-oncology, department of pediatrics, shiraz university of medical sciences, shiraz, iranسازمان اصلی تایید شده: دانشگاه علوم پزشکی شیراز (shiraz university of medical sciences)

background: burkitt lymphoma is a common subtype of non-hodgkin lymphoma in children. it has a rapid and aggressive clinical course with frequent involvement of bone marrow and central nervous system. systemic chemotherapy is the mainstay of the treatment for this malignancy in children. in this systematic review, we discuss autologous and allogeneic hematopoietic stem cell transplantation (hsc...

Journal: :international journal of hematology-oncology and stem cell research 0
seied-asadollah mousavi mina javadimoghadam ardeshir ghavamzadeh kamran alimoghaddam azadeh sayarifard seyed-hamidollah ghaffari

background: the study attempts to assess the relationship between chimerism analysis using polymerase chain reaction of short tandem repeat (str) and the incidence of chronic graft versus host disease (gvhd) as well as survival. methods: the retrospective cohort included all patients who received allo-hsct between 2005 to 2013. data collected by day +100 were reviewed in terms of the incidence ...

Journal: :iranian journal of allergy, asthma and immunology 0
ehteramolsadat hosseini malignant hematology and stem cell transplantation service, alfred hospital, monash university, melbourne, australia anthony p. schwarer malignant hematology and stem cell transplantation service, alfred hospital, monash university, melbourne, australia mehran ghasemzadeh australian centre for blood diseases, monash university, melbourne, australia

the  non-classical mhc  class-i mainly involves in the  regulation of  innate  immune responses where hla-e  plays a significant role in the cell identification by natural killer cells. hla-e is a main regulatory ligand for natural killer cells and given the importance of these effector cells in hematopoietic stem cell transplantation, we investigated the effect of hla-e polymorphisms on post-h...

آتشی, امیر, ابراهیمی, لیلا, احمد بیگی, ناصر, امید خدا, آزاده, ذنوبی, زهرا, سلیمانی, مسعود, نیکو گفتار, مهین, کاویانی, سعید,

Background and Objective: Nowadays, although umbilical cord blood is a commonly used source of hematopoietic stem cell, its low frequency of these cells is the main factor limiting its clinical application. The transplantation of hematopoietic stem cells derived from placenta tissue along with umbilical cord blood cells of the same sample may be an appropriate approach to solve this problem. In...

Journal: :iranian journal of blood and cancer 0
s mohammadi m shaiegan ka moghadam gr babaee s samiei a ghavamzadeh

background: it is suggested that ha-1 mismatching among hematopoietic stem cell transplanted recipients-donors is associated with acute graft-versus-host disease (agvhd). so the aim of this study was to evaluate ha-1 frequency and examine the correlation between ha-1 disparity and gvhd patients who received transplantation from a hla-identical sibling. samples and methods: the dna was extracted...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید